News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Norman Beischer Foundation boost for Preeclampsia & Spina Bifida research
Two exciting Hudson Institute projects in Women’s & Newborn Health have received welcome funding from the Norman Beischer Medical Research Foundation. Improving preeclampsia outcomes Associate Professor Miranda Davies-Tuck receives $74,117 for her project looking at better identification and treatment of preeclampsia, which she says remains one of the most challenging and unresolved problems in obstetric medicine.… Read more
-
Rare genetic discovery explains sex development differences in XY females
Thanks to their doctors in Hanoi and researchers at Hudson Institute of Medical Research, they have been identified as XY females, and the exact source of their genetic difference has been identified for the first time.… Read more
-
RANZCOG recognition for stillbirth researcher
Perinatal Epidemiologist Associate Professor Miranda Davies-Tuck has been awarded a RANZCOG Honorary Fellowship in recognition of her exceptional contribution to women’s health.… Read more
-
Senator shatters the silence around vaginal prolapse
A lone Senator from Tasmania has achieved in one speech what Hudson Institute of Medical Research has spent years attempting: to get the words vagina and prolapse in the nation’s media.… Read more
-
Heart Foundation funding boosts newborn health research
Two newborn health research projects at Hudson Institute are among 67 around Australia to receive funding from the Heart Foundation.… Read more
-
New pathway to Hudson Institute Cell Therapies expertise
Hudson Institute’s Hudson Institute Cell Therapies (HICT) platform is now part of Therapeutic Innovation Australia’s (TIA) Pipeline Accelerator scheme, making its specialised cell therapy infrastructure, services and expertise more accessible to researchers and biotechnology developers across Australia.… Read more
-
Funding to protect the brains of the most premature babies
A $100,000 Jack Brockhoff Foundation grant will support Hudson Institute researcher Dr Tegan White’s ground-breaking research into brain development in babies born at just 22–23 weeks’ gestation.… Read more
-
Fetal growth restriction research gets to the heart of the problem
The problems caused by fetal growth restriction (FGR) can persist well beyond birth, and a new study could explain why these babies face higher cardiac risks later in life – revealing how FGR rewires the heart’s metabolism.… Read more
-
International study shows brain impact of FGR
The dangers to the unborn child caused by Fetal Growth Restriction (FGR) are becoming better understood and now, researchers at Hudson Institute have identified specifically how it impacts brain development.… Read more
-
Hudson Institute and Monash University proposed to chart a new shared future for Australia’s Medical Research capability
The following is a joint statement from Hudson Institute of Medical Research and Monash University: Hudson Institute of Medical Research is proposed to formally integrate into Monash University, with full operational integration proposed in the first half of 2027. Monash and Hudson have a strong, longstanding relationship, and we are working together to support… Read more
Hudson News
Get the inside view on discoveries and patient stories